查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379098

分叉病變市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Bifurcation Lesions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球分叉病變市場規模達到23億美元。展望未來， IMARC Group預計到2028年市場規模將達到31億美元，2022-2028年複合年成長率（CAGR）為5.1%。

分叉病變是指鄰近重要側支（SB）起點的冠狀動脈變窄。由於血流湍流和高剪切應力，容易形成動脈粥狀硬化斑塊。使用分析、手術持續時間、X 光照射和長期追蹤等技術進行治療。此外，3D（3D）血管攝影和多層電腦斷層掃描用於測量分叉角。隨著設備、影像、輔助藥物治療和血管通路的進步，全球複雜的分叉病變病例的治療已成為可能。

分叉病變市場趨勢：

冠狀動脈疾病（CAD）發生率的顯著增加增加了分叉病變的風險。這是推動市場成長的關鍵因素之一。除此之外，創新設備的批准、保險覆蓋範圍的擴大和成像方式的改進也正在加強市場的成長。此外，老年人口的增加（更有可能患上醫療疾病），以及各國政府為報銷而採取的支持性舉措，正在支持市場的成長。醫療旅遊業的成長、微創（MI）手術需求的不斷增加以及醫療基礎設施的改善是促進市場成長的其他因素。除此之外，正在進行的新型治療技術研究正在推動市場發展。例如，研究人員正在研究 Szabo 2 支架技術對具有高危害風險或 SB 閉塞致命後果的複雜分叉病變的有效性。此外，對支架和球囊的廣泛臨床試驗，加上熟練醫療保健專業人員數量的增加，預計將降低與分叉病變治療相關的風險，並對市場產生積極影響。

本報告回答的關鍵問題

  • 2022年全球分叉病變市場規模有多大？
  • 2023-2028年全球分叉病變市場的預期成長率是多少？
  • COVID-19 對全球分叉病變市場有何影響？
  • 推動全球分叉病變市場的關鍵因素是什麼？
  • 基於應用的全球分叉病變市場區隔如何？
  • 全球分叉病變市場的重點區域有哪些？
  • 全球分叉病變市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球分叉病變市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按類型分類的市場細分

  • 一體式支架
    • 市場走向
    • 市場預測
  • 兩支架
    • 市場走向
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 冠狀動脈
    • 市場走向
    • 市場預測
  • 周圍血管
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic plc
    • Spectranetics (Koninklijke Philips NV)
    • Terumo Corporation
Product Code: SR112023A4003

Abstract

The global bifurcation lesions market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2022-2028.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

Bifurcation Lesions Market Trends:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bifurcation lesions market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on types and application.

Breakup by Types:

One-Stent

Two-Stent

Breakup by Application:

Coronary Vascular

Peripheral Vascular

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global bifurcation lesions market in 2022?
  • 2. What is the expected growth rate of the global bifurcation lesions market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global bifurcation lesions market?
  • 4. What are the key factors driving the global bifurcation lesions market?
  • 5. What is the breakup of the global bifurcation lesions market based on the application?
  • 6. What are the key regions in the global bifurcation lesions market?
  • 7. Who are the key players/companies in the global bifurcation lesions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bifurcation Lesions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Types

  • 6.1 One-Stent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Two-Stent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Peripheral Vascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Boston Scientific Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Cardinal Health
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Medtronic plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Spectranetics (Koninklijke Philips N.V.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Terumo Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
  • Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2022
  • Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2022
  • Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
  • Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
  • Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million US$), 2023-2028
  • Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Bifurcation Lesions Market: Competitive Structure
  • Table 6: Global: Bifurcation Lesions Market: Key Players